These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 9500630)

  • 1. Cardiac allograft rejection late after transplantation is a risk factor for graft coronary artery disease.
    Brunner-La Rocca HP; Schneider J; Künzli A; Turina M; Kiowski W
    Transplantation; 1998 Feb; 65(4):538-43. PubMed ID: 9500630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of patients not requiring endomyocardial biopsies late after cardiac transplantation.
    Brunner-La Rocca HP; Kiowski W
    Transplantation; 1998 Feb; 65(4):533-8. PubMed ID: 9500629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immunological algorithm to predict risk of high-grade rejection in cardiac transplant recipients.
    Itescu S; Tung TC; Burke EM; Weinberg AD; Mancini D; Michler RE; Suciu-Foca NM; Rose EA
    Lancet; 1998 Jul; 352(9124):263-70. PubMed ID: 9690405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural course of moderate cardiac allograft rejection (International Society for Heart Transplantation grade 2) early and late after transplantation.
    Brunner-La Rocca HP; Sütsch G; Schneider J; Follath F; Kiowski W
    Circulation; 1996 Sep; 94(6):1334-8. PubMed ID: 8822989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low incidence of transplant coronary artery disease in Chinese heart recipients.
    Hsu RB; Chu SH; Wang SS; Ko WJ; Chou NK; Lee CM; Chen MF; Lee YT
    J Am Coll Cardiol; 1999 May; 33(6):1573-7. PubMed ID: 10334426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late outcome after paediatric heart transplantation in Finland.
    Raissadati A; Pihkala J; Jahnukainen T; Jokinen E; Jalanko H; Sairanen H
    Interact Cardiovasc Thorac Surg; 2016 Jul; 23(1):18-25. PubMed ID: 27034098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allograft rejection of ISHLT grade >/=3A occurring late after heart transplantation--a distinct entity?
    Klingenberg R; Koch A; Schnabel PA; Zimmermann R; Sack FU; Haass M; Dengler TJ
    J Heart Lung Transplant; 2003 Sep; 22(9):1005-13. PubMed ID: 12957610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adult-size kidneys without acute tubular necrosis provide exceedingly superior long-term graft outcomes for infants and small children: a single center and UNOS analysis. United Network for Organ Sharing.
    Sarwal MM; Cecka JM; Millan MT; Salvatierra O
    Transplantation; 2000 Dec; 70(12):1728-36. PubMed ID: 11152105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreasing incidence of coronary disease in pediatric cardiac transplant recipients using increased immunosuppression.
    Addonizio LJ; Hsu DT; Douglas JF; Kichuk MR; Michler RE; Quaegebeur JM; Smith CR; Rose EA
    Circulation; 1993 Nov; 88(5 Pt 2):II224-9. PubMed ID: 8222158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for development of accelerated coronary artery disease in cardiac transplant recipients.
    Radovancevic B; Poindexter S; Birovljev S; Velebit V; McAllister HA; Duncan JM; Vega D; Lonquist J; Burnett CM; Frazier OH
    Eur J Cardiothorac Surg; 1990; 4(6):309-12; discussion 313. PubMed ID: 2361019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results of triple-drug-based immunosuppression in nonneonatal pediatric heart transplant recipients.
    Gajarski RJ; Smith EO; Denfield SW; Rosenblatt HM; Kearney D; Frazier OH; Radovancevic B; Price JK; Kertesz NJ; Towbin JA
    Transplantation; 1998 Jun; 65(11):1470-6. PubMed ID: 9645805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factor analysis for the major hazards following heart transplantation--rejection, infection, and coronary occlusive disease.
    Sharples LD; Caine N; Mullins P; Scott JP; Solis E; English TA; Large SR; Schofield PM; Wallwork J
    Transplantation; 1991 Aug; 52(2):244-52. PubMed ID: 1871797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of methotrexate on acute rejection and cardiac allograft vasculopathy in heart transplant recipients.
    Costanzo MR; Koch DM; Fisher SG; Heroux AL; Kao WG; Johnson MR
    J Heart Lung Transplant; 1997 Feb; 16(2):169-78. PubMed ID: 9059928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute cellular rejection and the subsequent development of allograft vasculopathy after cardiac transplantation.
    Raichlin E; Edwards BS; Kremers WK; Clavell AL; Rodeheffer RJ; Frantz RP; Pereira NL; Daly RC; McGregor CG; Lerman A; Kushwaha SS
    J Heart Lung Transplant; 2009 Apr; 28(4):320-7. PubMed ID: 19332257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus infection associated accelerated heart allograft arteriosclerosis may impair the late function of the graft.
    Koskinen P; Lemstrøm K; Mattila S; Häyry P; Nieminen MS
    Clin Transplant; 1996 Dec; 10(6 Pt 1):487-93. PubMed ID: 8996768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal.
    Mehra MR; Ventura HO; Chambers RB; Ramireddy K; Smart FW; Stapleton DD
    J Heart Lung Transplant; 1997 Jul; 16(7):743-51. PubMed ID: 9257256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocardial infiltrates in the transplanted heart: clinical significance emerging from the analysis of 5026 endomyocardial biopsy specimens.
    Costanzo-Nordin MR; Winters GL; Fisher SG; O'Sullivan J; Heroux AL; Kao W; Mullen GM; Johnson MR
    J Heart Lung Transplant; 1993; 12(5):741-7. PubMed ID: 8241211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute rejection and coronary artery disease in long-term survivors of heart transplantation.
    Narrod J; Kormos R; Armitage J; Hardesty R; Ladowski J; Griffith B
    J Heart Transplant; 1989; 8(5):418-20; discussion 420-1. PubMed ID: 2795285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of coronary artery disease after heart transplantation is increased in patients receiving low-dose cyclosporine, regardless of blood cyclosporine levels.
    Gamba A; Mamprin F; Fiocchi R; Senni M; Troise G; Ferrazzi P; Ferrara R; Corbetta G
    Clin Cardiol; 1997 Sep; 20(9):767-72. PubMed ID: 9294668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graft coronary artery disease is strongly related to the aetiology of heart failure and cellular rejections.
    Lindelöw B; Bergh C; Lamm C; Andersson B; Waagstein F
    Eur Heart J; 1999 Sep; 20(18):1326-34. PubMed ID: 10462467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.